Everything You Need to Know About Sunpeaks Ventures Inc (OTC:SNPK)

Sunpeaks Ventures Inc (OTC:SNPK)

Jun 5, 2012

Out of Nevada, Sunpeaks Ventures is a Junior US company with BC connections. Sunpeaks Ventures Incorporated is a distributor of over-the-counter vitamins and specialty drugs. This company caters to the healthcare provider market in the United States. As a wholly owned Healthcare Distribution Specialists, LLC subsidiary, Sunpeaks Ventures has recently released Clotamin.

Clotamin is an over-the-counter supplemental multivitamin product that was designed specifically to be taken by patients that are also on Warfarin, which is a blood thinner drug that had several adverse drug and food interactions as well as some side effects. Clotamin is intended to supplement and make up for these side effects as well as prepare the body for, and repair the body from the effects of Warfarin.

Sign up below to receive our Free Newsletter to start receiving our "Alerted Penny Stock" picks!!!

You MUST Sign Up In Order To Receive Our Free Penny Stock Picks!!!

In the multivitamin and supplement market, Sunpeaks Ventures has a unique niche, involving partnerships with sports teams as well as entering an agreement with NYC sports radio station WFAN 660AM. These moves have the target audience listening closely and paying attention to the benefits of this unique multivitamin product.

Aside from the multivitamin Clotamin, distributed by Sunpeaks Ventures, Healthcare Distribution Specialists also provides a complete line of other products including Plasma Derivatives, Vaccines, Surgical Products and others. Sunpeaks Ventures is the particular subsidiary that deals with Clotamin, however the market in other products carried by and HDS can bleed over.

Marketing challenges for a company like Sunpeaks Ventures are targeting the correct audience, which they seem to have accomplished already, and ramping up to total national distribution. This is a current goal of theirs, mentioned on the homepage for the company.

Sunpeaks Ventures (OTC:SNPK) has been on a financial rollercoaster, peaking at over $2.40 per share, but plummeted back down to under $0.06 per share and hasn't gained much confidence since. Is this company going to make a comeback? They have recently made some extremely extensive marketing efforts and are looking to make an attempt at a giant comeback. If it is successful, investors could have a chance to gain back losses, but with the previous failure as well as having gone into the pink for a while before finally disclosing Q10 numbers, this might be this company's final days.

Featured Companies

Legal Disclaimer & Risk Disclosure: The disclaimer is to be read and fully understood before using our site, or joining our email list. PLEASE NOTE WELL: The BestDamnPennyStocks.com employees are not Registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://www.BestDamnPennyStocks.com/legal_disclaimer.html Release of Liability: Through use of this website viewing or using you agree to hold BestDamnPennyStocks.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damage (monetary or otherwise), or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data.BestDamnPennyStocks' affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. BestDamnPennyStocks.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and BestDamnPennyStocks.com makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. Any claims or Statements should be deemed apocryphal. This is not a solicitation buy or sell any securities. BestDamnPennyStocks.com, nor any of its affiliates are not registered investment advisors or a broker dealers. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment.